To address the nationwide concern of costly immunotherapy agents, this article features health system inpatient and outpatient strategies that can help mitigate their costs.
Carina Verdier Dolan, PharmD, BCOP
Advertisement
Articles by Carina Verdier Dolan, PharmD, BCOP
Advertisement
Latest Updated Articles
- Evolving Practices in Managing Costly Immunotherapy
February 8th 2016
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
3
Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care
4
FSGS Treatment and Low IgAN Drug Uptake: Jai Radhakrishnan, MD, MS
5